Lipophilic il-2 production inhibitor-containing pharmaceutical compositions

Lipophilic IL-2 production inhibitor, and said lipophilic IL-2 production inhibitors discloses a pharmaceutical composition to suppress the amount of blood exposure comprising a base capable of lymph delivered by oral administration. According to the pharmaceutical composition to suppress blood exposure for reducing side effects of the lipophilic IL-2 production inhibitor, and capable of expressing the desired pharmacological effect.